In this issue:
- Tirzepatide for HFPEF and obesity
- Obicetrapib in high CV risk patients
- Intravenous ferric carboxymaltose in HF with iron deficiency
- Rural Māori experiences of accessing heart healthcare
- Catheter ablation or antiarrhythmic drugs for ventricular tachycardia
- Preoperative cardiorespiratory fitness: outcomes after hip/knee arthroplasty
- Invasive treatment strategy for older MI patients
- Kidney transplant outcomes of Māori and Pasifika in Australia
- Denosumab vs. bisphosphonates in dialysis patients: CV safety and fracture prevention
- Seasonal variation in MI hospitalisation and ischaemic heart disease deaths in NZ
Please login below to download this issue (PDF)